Fig. 3: Graphic representation of the cellular mechanisms involved in the increase in ferroptotic events. | Molecular Psychiatry

Fig. 3: Graphic representation of the cellular mechanisms involved in the increase in ferroptotic events.

From: Iron imbalance in neurodegeneration

Fig. 3

Ferroptosis leads to membrane destabilization, mitochondrial dysfunction, cytoskeletal rearrangements, and protein impairment. It is triggered by an imbalance between lipid hydroperoxide detoxification and iron-dependent ROS accumulation. The peroxidation of Polyunsaturated fatty acids (PUFAs) is limited by glutathione peroxidase 4 (GPX4), which utilizing glutathione (GSH), converts the lipid hydroperoxide in lipid alcohol. When equilibrium is lost, the oxidized lipid species (4-Hydroxynonenal and Malondialdehyde) accumulate in membranes, destabilizing them and leading to cell death. SLC7A11, solute carrier family 7 member 11 and SLC3A2, solute carrier family 3 member 2 allow the internalization of cystine need for GSH synthesis. A key ferroptotic player is glutathione depletion and/or the inactivation of glutathione-dependent antioxidant enzyme GPX4. Source of iron are heme and cytosolic ferritin degradation. Under conditions of iron restriction, NCOA4 binds to the H-subunit of ferritin, carrying it to lysosomes (ferritinophagy), where the protein is degraded and iron is released; during iron excess, NCOA4 is degraded by the ubiquitin–proteasome system, making cytosolic ferritin free to sequester iron.

Back to article page